The Basel-based life sciences group Novartis is hiving off some of its business activities that are not essential to its core business. The move will affect some 1,250 Novartis staff who will be transferred to other firms.
Negotiations are currently taking place with the French groups Elyo and Videndi for the management of Novartis's energy procurement and waste disposal operations. Talks are also being held with the Swiss-Swedish technology group ABB and Johnson Controls of the United States to take over Novartis's technical services operation.
In a statement, Novartis said that no employees would lose their jobs as a result of the changes. The restructuring is due to be completed by the end of this year.
Novartis announced five hundred job losses last September as the group continued to streamline operations and refocus on its core business in the life sciences sector.
swissinfo with agencies